rosiglitazone has been researched along with Berger Disease in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (66.67) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chan, LY; Guo, H; Lai, KN; Leung, JC; Xiao, J | 1 |
Chan, LY; Lai, KN; Leung, JC; Tang, SC; Xiao, J | 1 |
Chan, LY; Guo, H; Lai, KN; Leung, JC; Tang, SC | 1 |
3 other study(ies) available for rosiglitazone and Berger Disease
Article | Year |
---|---|
Protective effect of peroxisome proliferator-activated receptor-gamma agonists on activated renal proximal tubular epithelial cells in IgA nephropathy.
Topics: Cells, Cultured; Chromans; Epithelial Cells; Female; Glomerulonephritis, IGA; Humans; Inflammation; Kidney Tubules, Proximal; Male; PPAR gamma; Rosiglitazone; Thiazolidinediones; Troglitazone | 2009 |
Crosstalk between peroxisome proliferator-activated receptor-gamma and angiotensin II in renal tubular epithelial cells in IgA nephropathy.
Topics: Angiotensin II Type 1 Receptor Blockers; Anilides; Blotting, Western; Cells, Cultured; Culture Media, Conditioned; Epithelial Cells; Extracellular Signal-Regulated MAP Kinases; Female; Gene Expression Regulation; Glomerulonephritis, IGA; Humans; Immunoglobulin A; Intercellular Adhesion Molecule-1; Interleukin-6; Kidney Tubules; Losartan; Male; Mesangial Cells; NF-kappa B; PPAR gamma; Receptor Cross-Talk; Receptor, Angiotensin, Type 1; Reverse Transcriptase Polymerase Chain Reaction; Rosiglitazone; Signal Transduction; Thiazolidinediones | 2009 |
Additive effect of PPAR-γ agonist and ARB in treatment of experimental IgA nephropathy.
Topics: Analysis of Variance; Angiotensin II Type 1 Receptor Blockers; Animals; Blood Pressure; Drug Therapy, Combination; gamma-Globulins; Glomerulonephritis, IGA; Intercellular Adhesion Molecule-1; Kidney; Leukocytes, Mononuclear; Losartan; Mesangial Cells; Nephrectomy; PPAR gamma; Proteinuria; Rats; Rats, Inbred Lew; Receptor, Angiotensin, Type 1; Renin-Angiotensin System; Rosiglitazone; Thiazolidinediones; Transforming Growth Factor beta | 2011 |